Your browser doesn't support javascript.
loading
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany.
Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C; Hauschild, Axel; Herbst, Rudolf; Jiang, Ruixuan; Kähler, Katharina C; Krepler, Clemens; Kreuter, Alexander; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Pföhler, Claudia; Rudolph, Anja; Schadendorf, Dirk; Schiavone, Maximo; Schley, Gaston; Terheyden, Patrick; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weishaupt, Carsten; Welzel, Julia; Weichenthal, Michael.
  • Mohr P; Department of Dermatology, Elbe Kliniken Buxtehude, 21614 Buxtehude, Germany.
  • Scherrer E; Merck & Co., Inc., Kenilworth, NJ 07033, USA.
  • Assaf C; Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Bender M; Department of Dermatology and Venerolgy, HELIOS Klinikum Krefeld, 47805 Krefeld, Germany.
  • Berking C; Department of Dermatology, Elbe Kliniken Buxtehude, 21614 Buxtehude, Germany.
  • Chandwani S; Department of Dermatology, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen EMN, Deutsches Zentrum Immuntherapie, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Eigentler T; Merck & Co., Inc., Kenilworth, NJ 07033, USA.
  • Grimmelmann I; Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Gutzmer R; Department of Dermatology, University Hospital Tuebingen, 72076 Tuebingen, Germany.
  • Haferkamp S; Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, 30625 Hannover, Germany.
  • Hassel JC; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Campus Minden, 32429 Minden, Germany.
  • Hauschild A; Department of Dermatology, University of Regensburg, 93040 Regensburg, Germany.
  • Herbst R; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Jiang R; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
  • Kähler KC; Department of Dermatology, Helios Klinikum Erfurt, 99089 Erfurt, Germany.
  • Krepler C; Merck & Co., Inc., Kenilworth, NJ 07033, USA.
  • Kreuter A; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
  • Leiter U; Merck & Co., Inc., Kenilworth, NJ 07033, USA.
  • Loquai C; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, 46045 Oberhausen, Germany.
  • Meier F; Department of Dermatology, University Hospital Tuebingen, 72076 Tuebingen, Germany.
  • Pföhler C; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Rudolph A; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, 01307 Dresden, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
  • Schiavone M; Department of Dermatology, Saarland University Medical School, 66123 Homburg, Germany.
  • Schley G; IQVIA, 60549 Frankfurt, Germany.
  • Terheyden P; Clinic for Dermatology, Venereology and Allergy, University of Essen, 45147 Essen, Germany.
  • Ugurel S; Comprehensive Cancer Center (Westdeutsches Tumorzentrum), University Hospital Essen, Essen & German Cancer Consortium, 45147 Essen, Germany.
  • Ulrich J; IQVIA, 60549 Frankfurt, Germany.
  • Utikal J; Department of Dermatology, HELIOS Hospital Schwerin, 19055 Schwerin, Germany.
  • Weishaupt C; Department of Dermatology, University of Lübeck, 23562 Lübeck, Germany.
  • Welzel J; Clinic for Dermatology, Venereology and Allergy, University of Essen, 45147 Essen, Germany.
  • Weichenthal M; Department of Dermatology and Allergy, Skin Cancer Center, 06484 Quedlinburg, Germany.
Cancers (Basel) ; 14(7)2022 Apr 01.
Article en En | MEDLINE | ID: mdl-35406577
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article